How is Isosorbide Dinitrate (ISDN) drip administered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ISDN Drip Administration

Isosorbide dinitrate (ISDN) is administered as a continuous intravenous infusion, but nitroglycerin is strongly preferred for IV nitrate therapy in the United States, as ISDN is not the standard formulation for intravenous use. 1

Preferred Alternative: Nitroglycerin IV

The American College of Cardiology explicitly states that nitroglycerin is the only nitrate formulation available for intravenous use in the United States and recommends using nitroglycerin instead of ISDN for intravenous nitrate therapy. 1

Nitroglycerin IV Protocol

  • Starting dose: 5-10 mcg/min (some guidelines suggest 10-20 mcg/min) 2, 1
  • Titration: Increase by 5-10 mcg/min every 3-5 minutes based on blood pressure and symptom response 2, 1
  • Maximum dose: Typically 200 mcg/min 1
  • Preparation: Dilute in D5W or normal saline using non-PVC tubing 1
  • Half-life: Only several minutes, making it ideal for acute titration 1

ISDN IV Administration (When Used)

When ISDN is used intravenously (primarily outside the United States or in research settings):

Dosing Regimens

  • Bolus administration: 0.25 to 2.5 mg (3.0 to 40.0 mcg/kg) for acute situations 3
  • Continuous infusion: 0.125 to 0.332 mg/min (1.5 to 6.0 mcg/kg/min) 3
  • Alternative regimen: Rapid bolus of 2 to 6 mg followed by infusion of 2 to 5 mg/hr 4

Administration Technique

  • Slow titration with frequent blood pressure monitoring is mandatory to avoid large drops in systolic blood pressure 2
  • An arterial line is not routinely required but facilitates titration in patients with borderline pressures 2
  • Continuous infusion provides more modest and stable blood pressure reduction compared to bolus dosing 3

Critical Blood Pressure Parameters

Indications Based on Systolic BP

  • SBP >110 mmHg: Recommended for use 2
  • SBP 90-110 mmHg: May be used with extreme caution 2
  • SBP <90 mmHg: Absolute contraindication 2, 5

Blood Pressure Targets During Titration

  • Do not reduce systolic BP below 90 mmHg or >30 mmHg below baseline 1
  • In previously normotensive patients, do not titrate systolic BP below 110 mmHg 1
  • In hypertensive patients, do not reduce mean arterial pressure by >25% 1

Absolute Contraindications

  • Sildenafil use within 24 hours 1, 5
  • Tadalafil use within 48 hours 1, 5
  • Initial systolic BP <90 mmHg 1, 5
  • Marked bradycardia (<50 bpm) or tachycardia 1
  • Right ventricular infarction or inferior wall MI with RV involvement (extreme caution required due to risk of profound hypotension) 1, 5

Critical Monitoring Requirements

Hemodynamic Monitoring

  • Frequent blood pressure measurements are essential to avoid inadvertent systemic hypotension, which can cause reflex tachycardia and worsen myocardial ischemia 1
  • Monitor for paradoxical bradycardia and increased angina pectoris 5
  • Assess for signs of volume depletion before initiation 5

Special Populations Requiring Extreme Caution

  • Patients with inferior wall MI: Frequently associated with right ventricular infarction—these patients depend on adequate RV preload and can experience profound hypotension 2, 1
  • Volume-depleted patients: Already hypotensive patients are at high risk 5
  • Hypertrophic cardiomyopathy: Nitrate therapy may aggravate angina 5

Tolerance Development

  • Tachyphylaxis is common after 24-48 hours of continuous therapy, necessitating incremental dosing 2
  • Significant coronary vasodilating effects persist after 2-day infusion, but tolerance develops within 5 days 6
  • A nitrate-free interval of at least 10-14 hours daily is essential to prevent tolerance development 1

Adverse Effects Management

Common Side Effects

  • Headache: Most frequent side effect; can be managed with aspirin or acetaminophen without compromising efficacy 5
  • Hypotension: May be accompanied by lightheadedness, especially when standing 5
  • Dizziness: Related to blood pressure changes 5

Management of Hypotension

  • Leg elevation 1
  • Rapid fluid administration 1
  • Atropine if severe 1
  • Dose adjustment or temporary discontinuation 5

Clinical Context for Use

Primary Indications

  • Acute heart failure with SBP >110 mmHg: Decreases left and right heart filling pressures, systemic vascular resistance, and improves dyspnea 2
  • Unstable angina refractory to conventional therapy: Effective for recurrent chest pain at rest 4
  • Acute hypertension following cardiopulmonary bypass 3

Expected Hemodynamic Effects

  • Reduction in systemic blood pressure (23% systolic, 25% diastolic with bolus; 17% systolic, 11% diastolic with infusion) 3
  • Moderate venodilation with decreased central venous pressure 3
  • Minimal effect on heart rate 3, 7
  • Reduction in end-diastolic volume (>30 ml reduction sustained for up to 4 hours) 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.